Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jul 8, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Notice to Extend Eligibility for Submission of K99/R00 Pathway to Independence Award Applications (and Physician-Scientist K99/R00) due to COVIDrelated Disruptions
National Institute of Allergy and Infectious Diseases
- Notice of Pre-Application Webinar for "Radiation Oncology-Biology Integration Network (ROBIN) Centers: RFA-CA-21-040"
National Cancer Institute
- Updated NIGMS Guidelines for Funding Investigators with Substantial Other Research Support
National Institute of General Medical Sciences
- Notice Informing the Community of Application Form Issue with RFA-RM-21-016 NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
Office of Strategic Coordination (Common Fund)
- Request for Information (RFI): Call for Input into NICHDs Best Pharmaceuticals for Children Act Priorities for 2021 2022
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Request for Information: Developing Consent Language for Future Use of Data and Biospecimens
National Institutes of Health
Notice of Changes to Funding Opportunities
- Notice of Change to Award Information for RFA-AG-22-018 Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed)
National Institute on Aging
- Notice of Correction to Application Types Allowed for PAR-21-197, NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
National Institute of Dental and Craniofacial Research
Requests for Proposal
- Request for Proposals (RFP): Centers for Research on Structural Biology of Infectious Diseases 75N93021R00009
National Institute of Allergy and Infectious Diseases
- Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)
- Extramural Loan Repayment Program for Pediatric Research (LRP-PR)
- Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)
- Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)
- Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
- Extramural Loan Repayment Program for Research in Emerging Areas Critical to Human Health (LRP-REACH)
National Institutes of Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed)
National Institutes of Health
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
- Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects
Office of Disease Prevention
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
- Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects
Office of Disease Prevention
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
Funding Opportunities
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
National Institutes of Health
John E. Fogarty International Center
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of the Director, NIH
Office of Research on Women's Health
- NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)
National Eye Institute
- Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01 Clinical Trial Not Allowed)
National Institute of General Medical Sciences
- Exploratory Studies to Investigate the Mechanisms of Interrelationship between Sleep and Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans Required)
National Institute on Drug Abuse
- Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed)
- Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R21 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
National Cancer Institute
- New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional)
National Human Genome Research Institute
National Institute of Biomedical Imaging and Bioengineering
Office of the Director, NIH
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.